STS: Score stratifies risks for isolated tricuspid valve surgery patients | CHEST Physician
The Society of Thoracic Surgery Risk Score as a Predictor of 30-Day Mortality in Transcatheter vs Surgical Aortic Valve Replacement: A Single-Center Experience and its Implications for the Development of a TAVR
View Image
STS 2018 Risk Model Calculator
Imprimir artículo
Cómo evaluamos, seleccionamos y autorizamos el paciente para TAVI.
PUE Calculator - What is PUE & How to Calculate
Abstract 18908: Transcutaneous Aortic Valve Replacement - 30 Day and 1 Year Outcomes Using Conscious Sedation in Patients Stratified by STS Risk Score | Circulation
30249-2.fp.png "STS RISK SCORE AS PREDICTOR OF 30-DAY MORTALITY IN TRANSCATHETER VERSUS SURGICAL AORTIC VALVE REPLACEMENT | Journal of the American College of Cardiology")
STS RISK SCORE AS PREDICTOR OF 30-DAY MORTALITY IN TRANSCATHETER VERSUS SURGICAL AORTIC VALVE REPLACEMENT | Journal of the American College of Cardiology
Estratificación del riesgo para la toma de decisiones en revascularización miocárdic
STS 2018 Risk Model Calculator
2005 STS risk scoring system | Download Table
STS 2018 Risk Model Calculator
Comparison of EuroSCORE, EuroSCORE II, and STS score (modified from... | Download Table
Aortic Stenosis and TAVR - ppt download
EuroSCORE risk factors, their additive weights and beta coefficients | Download Table
The application of European system for cardiac operative risk evaluation II (EuroSCORE II) and Society of Thoracic Surgeons (STS) risk-score for risk stratification in Indian patients undergoing cardiac surgery. | Semantic Scholar
Online STS Risk Calculator
The Society of Thoracic Surgery Risk Score as a Predictor of 30-Day Mortality in Transcatheter vs Surgical Aortic Valve Replacement: A Single-Center Experience and its Implications for the Development of a TAVR
Escalas Predictivas de Riesgo Perioperatorio : WFSA - Resources
RISK PREDICTION IN TAVR
TOOLKIT: TRANSCATHETER AORTIC VALVE IMPLANTATION
The Society of Thoracic Surgery Risk Score as a Predictor of 30-Day Mortality in Transcatheter vs Surgical Aortic Valve Replacement: A Single-Center Experience and its Implications for the Development of a TAVR
